PharMerica Reaches Analyst Target Price
August 03, 2017 at 09:09 AM EDT
In recent trading, shares of PharMerica Corp (PMC) have crossed above the average analyst 12-month target price of $28.00, changing hands for $28.95/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..